Serono invests $200m in Israeli facility
Serono has unveiled a $200 million (€168m) investment in an Israeli facility that will be used to produce Rebif, the company's drug treatment for multiple sclerosis.
Archives for November 21, 2003
Stability testing aids drug discovery
ESA has developed a set of oxidative stability tools that could allow compounds with unfavourable characteristics to be weeded out at an early stage of development.
Grant helps Devgen explore drug mechanisms
Belgium's Devgen has been awarded a €1.9 million technology development grant from the Flemish government to develop a technology to identify the molecular target of human drugs.
Merck drops diabetes drug on cancer link
Merck & Co continued a run of bad luck in its product development portfolio yesterday with the news that it had terminated the development of a drug to treat diabetes.
US makes firm commitment to nanotechnology
The US has passed a new bill that will see the country invest €3.1 billion in nanotechnology over the next four years and should cement its position as a leader in this emerging technology sector.
Rhodia reveals job losses
Rhodia has revealed the extent of job cuts that will take place in the wake of its restructuring exercise, initiated in response to the financial pressures facing the chemicals group.